Pinkawa M - Search Results

1

Surgical resection of urological tumor metastases following medical treatment.

Heidenreich A, Wilop S, Pinkawa M, Porres D, Pfister D. Heidenreich A, et al. Among authors: pinkawa m. Dtsch Arztebl Int. 2012 Sep;109(39):631-7. doi: 10.3238/arztebl.2012.0631. Epub 2012 Sep 28. Dtsch Arztebl Int. 2012. PMID: 23093995 Free PMC article. Review.

2

Rectal morbidity after permanent interstitial brachytherapy for prostate cancer--impact of day 1 vs. day 30 computed tomography-based postimplant dosimetry.

Pinkawa M, Piroth MD, Holy R, Klotz J, Nussen S, Borchers H, Heidenreich A, Eble MJ. Pinkawa M, et al. Brachytherapy. 2010 Jan-Mar;9(1):1-7. doi: 10.1016/j.brachy.2009.04.003. Epub 2009 Sep 3. Brachytherapy. 2010. PMID: 19733126 Clinical Trial.

3

Prostate-specific antigen kinetics following external-beam radiotherapy and temporary (Ir-192) or permanent (I-125) brachytherapy for prostate cancer.

Pinkawa M, Piroth MD, Holy R, Fischedick K, Schaar S, Borchers H, Heidenreich A, Eble MJ. Pinkawa M, et al. Radiother Oncol. 2010 Jul;96(1):25-9. doi: 10.1016/j.radonc.2010.02.010. Epub 2010 Mar 16. Radiother Oncol. 2010. PMID: 20231039

4

Stereotactic body radiation therapy (SBRT) for treatment of adrenal gland metastases from non-small cell lung cancer.

Holy R, Piroth M, Pinkawa M, Eble MJ. Holy R, et al. Among authors: pinkawa m. Strahlenther Onkol. 2011 Apr;187(4):245-51. doi: 10.1007/s00066-011-2192-z. Epub 2011 Mar 21. Strahlenther Onkol. 2011. PMID: 21424513

5

Low-dose rate brachytherapy for men with localized prostate cancer.

Peinemann F, Grouven U, Hemkens LG, Bartel C, Borchers H, Pinkawa M, Heidenreich A, Sauerland S. Peinemann F, et al. Among authors: pinkawa m. Cochrane Database Syst Rev. 2011 Jul 6;(7):CD008871. doi: 10.1002/14651858.CD008871.pub2. Cochrane Database Syst Rev. 2011. PMID: 21735436 Review.

6

Permanent interstitial low-dose-rate brachytherapy for patients with localised prostate cancer: a systematic review of randomised and nonrandomised controlled clinical trials.

Peinemann F, Grouven U, Bartel C, Sauerland S, Borchers H, Pinkawa M, Heidenreich A, Lange S. Peinemann F, et al. Among authors: pinkawa m. Eur Urol. 2011 Nov;60(5):881-93. doi: 10.1016/j.eururo.2011.06.044. Epub 2011 Jun 29. Eur Urol. 2011. PMID: 21763066 Review.

7

Urinary morbidity after permanent prostate brachytherapy - impact of dose to the urethra vs. sources placed in close vicinity to the urethra.

Pinkawa M, Holy R, Piroth MD, Klotz J, Pfister D, Heidenreich A, Eble MJ. Pinkawa M, et al. Radiother Oncol. 2012 May;103(2):247-51. doi: 10.1016/j.radonc.2011.12.011. Epub 2012 Jan 31. Radiother Oncol. 2012. PMID: 22300607

8

Local prostate cancer radiotherapy after prostate-specific antigen progression during primary hormonal therapy.

Pinkawa M, Piroth MD, Holy R, Djukic V, Klotz J, Pfister D, Heidenreich A, Eble MJ. Pinkawa M, et al. Radiat Oncol. 2012 Dec 10;7:209. doi: 10.1186/1748-717X-7-209. Radiat Oncol. 2012. PMID: 23227960 Free PMC article.

9

Transurethral resection of the prostate after radiotherapy for prostate cancer: impact on quality of life.

Pinkawa M, Klotz J, Djukic V, Petz D, Holy R, Eble MJ. Pinkawa M, et al. Int J Urol. 2014 Sep;21(9):899-903. doi: 10.1111/iju.12460. Epub 2014 Apr 13. Int J Urol. 2014. PMID: 24724611

10

Prediction of survival outcomes following postoperative radiotherapy after radical prostatectomy for prostate cancer.

Leufgens F, Berneking V, Vögeli TA, Kirschner-Hermanns R, Eble MJ, Pinkawa M. Leufgens F, et al. Among authors: pinkawa m. Acta Oncol. 2020 Feb;59(2):157-163. doi: 10.1080/0284186X.2019.1675905. Epub 2019 Oct 9. Acta Oncol. 2020. PMID: 31596159

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Search Page

Filters